HP
CYTK icon

Havemeyer Place’s Cytokinetics CYTK Stock Holding History

Havemeyer Place’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$565K Buy
+6,631
New +$476K 0.06% 387
2026
Q1 		– Sell
-7,923
Closed -$503K – 562
2025
Q4 		$503K Buy
+7,923
New +$493K 0.1% 320

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Havemeyer Place's CYTK Position: Q2 2026 in Review

Havemeyer Place opened a new position in Cytokinetics (CYTK) in Q2 2026: 6,631 shares worth $565K. The stake represents 0.06% of the portfolio and ranks #387 among its holdings. This is a return to the name: Havemeyer Place previously reported a position in CYTK as recently as Q4 2025.

Havemeyer Place first reported a position in CYTK in Q4 2025 and has held it in 2 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Havemeyer Place held 6,631 shares of Cytokinetics worth $565K as of Q2 2026.
  • Cytokinetics was a new Havemeyer Place position in Q2 2026.
  • Cytokinetics made up 0.06% of Havemeyer Place's portfolio in Q2 2026, its #387 holding.
  • Havemeyer Place first reported a position in Cytokinetics in Q4 2025 and has held it in 2 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Havemeyer Place's 13F filing for Q2 2026, filed 13 Aug 2026.